Home » Topics » BioWorld Science

BioWorld Science
RSS

Maxamine enters phase III for malignant melanoma

July 15, 1997

Mechanism of topical absorption of antiandrogen drug investigated

July 15, 1997

Englitazone mechanism of antidiabetic activity studied in vitro

July 15, 1997

New treatment reported for diaper dermatitis

July 15, 1997

New insights into glaucoma and implications for drug therapy

July 15, 1997

Rutaecarpine, a vasorelaxant component of an herbal drug

July 15, 1997

FDA approves antibacterial generic from Mylan

July 14, 1997

Mylan antianxiety/antipsychotic generic approved by FDA

July 14, 1997

Fujisawa reduces stake in Fujisawa Synthelabo

July 14, 1997

Novartis' R&D pipeline

July 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...